Enzon Pharmaceuticals Inc (ENZN)
0.0795
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Enzon Pharmaceuticals Price to Book Value: 2.136 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 2.136 |
| November 12, 2024 | 2.123 |
| November 11, 2024 | 2.274 |
| November 08, 2024 | 2.284 |
| November 07, 2024 | 2.284 |
| November 06, 2024 | 2.284 |
| November 05, 2024 | 2.413 |
| November 04, 2024 | 2.116 |
| November 01, 2024 | 2.217 |
| October 31, 2024 | 2.418 |
| October 30, 2024 | 2.069 |
| October 29, 2024 | 2.418 |
| October 28, 2024 | 2.150 |
| October 25, 2024 | 2.690 |
| October 24, 2024 | 2.821 |
| October 23, 2024 | 2.821 |
| October 22, 2024 | 2.929 |
| October 21, 2024 | 3.356 |
| October 18, 2024 | 3.356 |
| October 17, 2024 | 3.150 |
| October 16, 2024 | 3.150 |
| October 15, 2024 | 3.150 |
| October 14, 2024 | 2.956 |
| October 11, 2024 | 3.113 |
| October 10, 2024 | 2.960 |
| Date | Value |
|---|---|
| October 09, 2024 | 3.128 |
| October 08, 2024 | 2.958 |
| October 07, 2024 | 3.485 |
| October 04, 2024 | 2.956 |
| October 03, 2024 | 3.756 |
| October 02, 2024 | 3.09 |
| October 01, 2024 | 3.219 |
| September 30, 2024 | 3.762 |
| September 27, 2024 | 2.930 |
| September 26, 2024 | 2.955 |
| September 25, 2024 | 2.955 |
| September 24, 2024 | 3.629 |
| September 23, 2024 | 2.979 |
| September 20, 2024 | 3.438 |
| September 19, 2024 | 3.438 |
| September 18, 2024 | 3.231 |
| September 17, 2024 | 3.297 |
| September 16, 2024 | 2.930 |
| September 13, 2024 | 3.078 |
| September 12, 2024 | 3.089 |
| September 11, 2024 | 3.055 |
| September 10, 2024 | 3.246 |
| September 09, 2024 | 3.419 |
| September 06, 2024 | 3.663 |
| September 05, 2024 | 3.817 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.022
Minimum
Mar 18 2020
10.04
Maximum
Aug 08 2022
4.146
Average
4.152
Median
Jul 01 2024
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.574 |
| Perspective Therapeutics Inc | 1.807 |
| Protalix BioTherapeutics Inc | 3.448 |
| Electromed Inc | 5.543 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 60.73 |
| Price to Free Cash Flow | 4.367 |
| Price | 0.0795 |
| Earnings Yield | 1.65% |
| Market Cap | 5.900M |
| Normalized PE Ratio | 35.96 |